High-throughput human immunodeficiency virus type 1(HIV-1) full replication assay that includes HIV-1 vif as an antiviral target

High-throughput human immunodeficiency virus type 1(HIV-1) full replication assay that includes HIV-1 vif as an antiviral target
复制标题

DOI:
10.1128/aac.49.9.3833-3841.2005
复制
发表时间:
2005-09-01
影响因子:
4.9
通讯作者:
Blair, WS
Blair, WS
中科院分区:
医学2区
文献类型:
--
作者:
Cao, J;Isaacson, J;Blair, WS

文献摘要

被引文献

相似文献

抗病毒筛选已被证明可用于鉴定新型人类免疫缺陷病毒1型(HIV-1)抑制剂。在这项研究中,我们描述了一种HIV-1完全复制(HIV-1 Rep)检测方法,该方法结合了T细胞系中复制所需的所有靶标,包括HIV-1 Vif基因。HIV-1 Rep检测试剂盒旨在对晚期和早期抑制剂表现出最佳灵敏度,以最大限度地提高筛选中识别新型靶向抗病毒化合物的可能性。此外,HIV-1 Rep检测试剂盒的灵活性允许在不同T细胞系中快速评价抗病毒化合物对不同病毒株的抗病毒作用,而无需显著修改检测试剂盒形式。我们证明了HIV-1 Rep检测具有以下特征(例如,有利的Z ′值)与384孔格式中的高通量筛选相容。HIV-1 Rep测定的实用性在> 10(6)种化合物的高通量筛选中得到证实。据我们所知,这项研究代表了HIV-1抗病毒筛选的第一个例子,其中包括Vif作为功能靶标,并在工业规模上进行。
Antiviral screens have proved useful for the identification of novel human immunodeficiency virus type 1 (HIV-1) inhibitors. In this study, we describe an HIV-1 full replication (HIV-1 Rep) assay that incorporates all of the targets required for replication in T-cell lines, including the HIV-1 Vif gene. The HIV-1 Rep assay was designed to exhibit optimal sensitivity to late-stage as well as early-stage inhibitors to maximize the likelihood of identification of novel target antiviral compounds in a screen. In addition, the flexibility of the HIV-1 Rep assay allows the rapid evaluation of antiviral compounds against different virus strains in different T-cell lines without significant modification of the assay format. We demonstrate that the HIV-1 Rep assay exhibits characteristics (e.g., a favorable Z' value) compatible with high-throughput screening in a 384-well format. The utility of the HIV-1 Rep assay was demonstrated in a high-throughput screen of > 10(6) compounds. To our knowledge, this study represents the first example of an HIV-1 antiviral screen that includes Vif as a functional target and was executed on an industrial scale.